SNYR Fundamental Analysis - SYNERGY CHC CORP

Fundamental Rating

Taking everything into account, SNYR scores 4 out of 10 in our fundamental rating. SNYR was compared to 35 industry peers in the Personal Care Products industry. While SNYR is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on SNYR.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SNYR was profitable.

The reported net income has been mixed in the past 5 years: SNYR reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: SNYR reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of SNYR (13.57%) is better than 85.71% of its industry peers.

SNYR's Return On Invested Capital of 37.12% is amongst the best of the industry. SNYR outperforms 97.14% of its industry peers.

		Industry Rank	Sector Rank
ROA	13.57%
ROE	N/A
ROIC	37.12%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of SNYR (6.10%) is better than 74.29% of its industry peers.

The Operating Margin of SNYR (16.65%) is better than 80.00% of its industry peers.

In the last couple of years the Operating Margin of SNYR has grown nicely.

Looking at the Gross Margin, with a value of 67.87%, SNYR is in line with its industry, outperforming 60.00% of the companies in the same industry.

SNYR's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	16.65%
PM (TTM)	6.1%
GM	67.87%

OM growth 3YN/A

OM growth 5Y22.69%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-0.29%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNYR is creating value.

Compared to 1 year ago, SNYR has more shares outstanding

Compared to 5 years ago, SNYR has more shares outstanding

The debt/assets ratio for SNYR has been reduced compared to a year ago.

2.2 Solvency

SNYR has an Altman-Z score of 0.73. This is a bad value and indicates that SNYR is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 0.73, SNYR is not doing good in the industry: 71.43% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	0.73

ROIC/WACC3.68

WACC10.08%

2.3 Liquidity

A Current Ratio of 1.91 indicates that SNYR should not have too much problems paying its short term obligations.

SNYR has a Current ratio (1.91) which is in line with its industry peers.

A Quick Ratio of 1.62 indicates that SNYR should not have too much problems paying its short term obligations.

SNYR has a better Quick ratio (1.62) than 68.57% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.91
Quick Ratio	1.62

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for SNYR have decreased strongly by -67.60% in the last year.

The Revenue for SNYR has decreased by -18.57% in the past year. This is quite bad

SNYR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.48% yearly.

EPS 1Y (TTM)-67.6%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)-18.57%

Revenue growth 3YN/A

Revenue growth 5Y3.48%

Sales Q2Q%N/A

3.2 Future

SNYR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.70% yearly.

Based on estimates for the next years, SNYR will show a very strong growth in Revenue. The Revenue will grow by 20.94% on average per year.

EPS Next Y33.33%

EPS Next 2Y41.42%

EPS Next 3Y37.7%

EPS Next 5YN/A

Revenue Next Year34.06%

Revenue Next 2Y25.98%

Revenue Next 3Y20.94%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.14 indicates a correct valuation of SNYR.

Based on the Price/Earnings ratio, SNYR is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.

SNYR is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.

Based on the Price/Forward Earnings ratio of 4.63, the valuation of SNYR can be described as very cheap.

SNYR's Price/Forward Earnings ratio is rather cheap when compared to the industry. SNYR is cheaper than 97.14% of the companies in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 35.33, SNYR is valued rather cheaply.

		Industry Rank	Sector Rank
PE	12.14
Fwd PE	4.63

4.2 Price Multiples

71.43% of the companies in the same industry are more expensive than SNYR, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	9.05

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as SNYR's earnings are expected to grow with 37.70% in the coming years.

PEG (NY)0.36

PEG (5Y)N/A

EPS Next 2Y41.42%

EPS Next 3Y37.7%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SNYR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SYNERGY CHC CORP

NASDAQ:SNYR (7/15/2025, 8:23:15 PM)

After market: 3.35 -0.05 (-1.47%)

3.4

+0.01 (+0.29%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)05-15 2025-05-15/bmo

Earnings (Next)N/A N/A

Inst Owners11.39%

Inst Owner ChangeN/A

Ins Owners8.21%

Ins Owner Change0.02%

Market Cap30.63M

Analysts82.86

Price Target10.2 (200%)

Short Float %1.23%

Short Ratio0.41

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-25.07%

Min EPS beat(2)-90.2%

Max EPS beat(2)40.06%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-7.9%

Min Revenue beat(2)-11.25%

Max Revenue beat(2)-4.54%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-38.46%

EPS NY rev (1m)-20%

EPS NY rev (3m)-18.64%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)3164.71%

Revenue NY rev (1m)0%

Revenue NY rev (3m)3107.21%

Valuation

		Industry Rank	Sector Rank
PE	12.14
Fwd PE	4.63
P/S	0.88
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	9.05

EPS(TTM)0.28

EY8.24%

EPS(NY)0.73

Fwd EY21.6%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS3.87

BVpS-1.74

TBVpS-1.76

PEG (NY)0.36

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	13.57%
ROE	N/A
ROCE	76.43%
ROIC	37.12%
ROICexc	37.71%
ROICexgc	38.5%
OM	16.65%
PM (TTM)	6.1%
GM	67.87%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5Y22.69%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-0.29%

F-ScoreN/A

Asset Turnover2.22

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	4.72
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.91
Quick Ratio	1.62
Altman-Z	0.73

F-ScoreN/A

WACC10.08%

ROIC/WACC3.68

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-67.6%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y33.33%

EPS Next 2Y41.42%

EPS Next 3Y37.7%

EPS Next 5YN/A

Revenue 1Y (TTM)-18.57%

Revenue growth 3YN/A

Revenue growth 5Y3.48%

Sales Q2Q%N/A

Revenue Next Year34.06%

Revenue Next 2Y25.98%

Revenue Next 3Y20.94%

Revenue Next 5YN/A

EBIT growth 1Y-46.32%

EBIT growth 3YN/A

EBIT growth 5Y26.96%

EBIT Next Year68.78%

EBIT Next 3Y35.04%

EBIT Next 5YN/A

FCF growth 1Y-1239.06%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1239.06%

OCF growth 3YN/A

OCF growth 5YN/A

SYNERGY CHC CORP (SNYR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens